In this blog Hep C U Later Programme Lead, Deanne Burch, outlines the planned key milestones in the journey to say Hep C U Later.
Since 2020 Hep C U Later have been commissioned to provide support and coordination for the micro-elimination of hepatitis C within the NHS Addiction Provider Alliance member Trusts*. This programme has now been fully funded by NHS England’s Hepatitis C Elimination Programme.
In 2022 Hep C U Later were commissioned by NHS England to provide an additional Engagement Programme**, focusing on providing awareness, resources and engagement to key healthcare professional groups across England.
So far the Hep C U Later programmes have both seen some great successes – the micro-elimination of hepatitis C in 20 NHS community drug and alcohol services, the broad engagement and reach demonstrated by the new Engagement Programme and the vast development of resources, best practice, and training.
Critical to the success of these programmes has been the effectiveness of cross-system collaborations, the continued commitment of individual champions, and the united vision we all share. It is also fair to say that we would not be so close to achieving our goals if it were not for the enabling effect of NHS England and our other vital stakeholders.
We have achieved a great many things collectively and these achievements are detailed fully in our Impact Reports available on our resource page.
Over the next two years we have three very clear aims for our programme focused on supporting community drug and alcohol services:
In the rest of this blog we share a brief outline of our planned work and strategy for achieving these ambitions.
We have been working towards this aim since the start of the programme in 2020, systematically developing our strategies to support services achieve this very challenging goal. We will:
This aim is focused on ensuring services are in the best position possible to sustain micro-elimination when the programme ends. To do this we will:
Key to upholding the legacy of what has been achieved so far is ensuring that effective approaches to prevention are in place. This means not only looking for opportunities to improve, but to also share the good practice we see. Our key focus will be harm reduction interventions and widening access to testing outside of drug and alcohol services. To do this we will:
Collectively we have achieved some incredible milestones since the start of the Hep C U Later programme, and this has fed into the good outcomes seen from the work across England led by the NHS England Hepatitis C Elimination Team. This is work that has improved health, saved lives, reduced liver transplants, prevented liver disease and liver cancer, as well as provided hepatitis C treatment to some of the most deprived populations in the country.
Hep C U Later are now in the phase of using our expertise to support the remaining services to reach micro-elimination, ensuring strategies are in place to sustain it, and widening our focus even further. A critical part of how we sustain micro-elimination is through how we approach prevention, and how we align hepatitis C with other health and wellbeing interventions being prioritised within the system. As we progress with these planned streams of work we will endeavour to continue collaborating, building on what works, and updating everyone who has been involved in the Hep C U Later programme so far.
Thank you to everyone who has, and will, say ‘Hep C U Later’, we are truly grateful for your support.
*Funding for the drug and alcohol focused Hep C U Later programme was funded by Gilead Sciences from 1/1/20-31/3/24 as part of the NHS England hepatitis C elimination tender. From the 1/4/24 the Hep C U Later drug and alcohol focused programme was funded by NHS England’s Hepatitis C Elimination Programme.
**The Engagement Programme is an additional initiative provided by Inclusion, part of Midlands Partnership University NHS Foundation Trust enabled through the existing NHS Addiction Provider Alliance initiative.